Lista de obras - Johannes Werzowa - Dominio Público Uruguay

A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation.

artículo científico publicado en 2018

Addressing uncertainties in renal transplantation: hypomagnesemia and the case of diabetes prevention.

artículo científico

Antidiabetic therapy in post kidney transplantation diabetes mellitus.

artículo científico publicado en 2015

Biological action of rapamycin in renal transplantation.

artículo científico publicado en 2008

Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial.

artículo científico publicado en 2012

Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.

artículo científico publicado en 2010

CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages.

artículo científico publicado en 2012

Case report: spontaneous rupture of spleen in patient with Plasmodium ovale malaria

artículo científico publicado en 2015

Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus

artículo científico publicado en 2015

Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients

artículo científico publicado en 2016

Dual inhibition of EGFR and mTOR pathways in small cell lung cancer.

artículo científico publicado en 2010

Early basal insulin therapy decreases new-onset diabetes after renal transplantation.

artículo científico publicado en 2012

Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patients.

artículo científico publicado en 2011

Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.

artículo científico publicado en 2016

Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.

artículo científico publicado en 2013

Expression and regulation of HTRA1 during chick and early mouse development.

artículo científico publicado en 2008

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo

artículo científico publicado en 2009

Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status.

artículo científico publicado en 2013

Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake

artículo científico publicado en 2011

Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.

artículo científico publicado en 2013

Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation

scientific article published on 05 July 2019

Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept.

artículo científico publicado en 2009

Molecular regulation of the renin-angiotensin system in haemodialysis patients

artículo científico publicado en 2016

Molecular regulation of the renin-angiotensin system in haemodialysis patients.

artículo científico publicado en 2014

Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

artículo científico publicado en 2013

Post-transplantation diabetes mellitus: evaluation of treatment strategies.

artículo científico publicado en 2015

Primary External Stenting of an Autogenous Brachial-Basilic Upper Arm Transposition

scientific article published on 25 November 2019

Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy.

artículo científico publicado en 2015

Restoration of renal function does not correct impairment of uremic HDL properties

artículo científico publicado en 2014

Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002.

artículo científico publicado en 2008

Targeting the dysregulated mammalian target of rapamycin pathway in organ transplantation: killing 2 birds with 1 stone ⬇️

artículo científico publicado el 17 de marzo de 2011

The diagnosis of posttransplantation diabetes mellitus: meeting the challenges.

artículo científico

Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma and

Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo.

artículo científico publicado en 2010

Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial

artículo científico publicado en 2013

mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.

artículo científico publicado en 2008

Lista de obras de Johannes Werzowa

A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation.

Addressing uncertainties in renal transplantation: hypomagnesemia and the case of diabetes prevention.

Antidiabetic therapy in post kidney transplantation diabetes mellitus.

Biological action of rapamycin in renal transplantation.

Blood volume-monitored regulation of ultrafiltration in fluid-overloaded hemodialysis patients: study protocol for a randomized controlled trial.

Bortezomib for the treatment of chronic antibody-mediated kidney allograft rejection: a case report.

CMV late phase-induced mTOR activation is essential for efficient virus replication in polarized human macrophages.

Case report: spontaneous rupture of spleen in patient with Plasmodium ovale malaria

Comparison of glycemic control and variability in patients with type 2 and posttransplantation diabetes mellitus

Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients

Dual inhibition of EGFR and mTOR pathways in small cell lung cancer.

Early basal insulin therapy decreases new-onset diabetes after renal transplantation.

Effect of leptin on polymorphonuclear leucocyte functions in healthy subjects and haemodialysis patients.

Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.

Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.

Expression and regulation of HTRA1 during chick and early mouse development.

FDG uptake is a surrogate marker for defining the optimal biological dose of the mTOR inhibitor everolimus in vivo

Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status.

Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake

Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.

Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation

Late onset Pneumocystis pneumonia in renal transplantation after long-term immunosuppression with belatacept.

Molecular regulation of the renin-angiotensin system in haemodialysis patients

Molecular regulation of the renin-angiotensin system in haemodialysis patients.

Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

Post-transplantation diabetes mellitus: evaluation of treatment strategies.

Primary External Stenting of an Autogenous Brachial-Basilic Upper Arm Transposition

Prophylactic CMV therapy does not improve three-yr patient and graft survival compared to preemptive therapy.

Restoration of renal function does not correct impairment of uremic HDL properties

Suppression of mTOR complex 2-dependent AKT phosphorylation in melanoma cells by combined treatment with rapamycin and LY294002.

Targeting the dysregulated mammalian target of rapamycin pathway in organ transplantation: killing 2 birds with 1 stone ⬇️

The diagnosis of posttransplantation diabetes mellitus: meeting the challenges.

Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma and

Vertical inhibition of the mTORC1/mTORC2/PI3K pathway shows synergistic effects against melanoma in vitro and in vivo.

Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial

mTOR inhibition sensitizes gastric cancer to alkylating chemotherapy in vivo.